Sionna Therapeutics (SION) Amortizatization of Intangibles (2024 - 2026)
Sionna Therapeutics' (SION) quarterly Amortizatization of Intangibles came in at $200000.0 in Q1 2026, down 71.31% year-on-year from $697000.0 in Q1 2025, and down 59.27% quarter-over-quarter from $491000.0 in Q4 2025.
Sionna Therapeutics (SION) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting $200000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $200000.0, down 71.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 54.3% YoY), and the FY2025 annual result was $2.0 million, down 34.62% from the prior year.
- Amortizatization of Intangibles came in at $200000.0 for Q1 2026 at Sionna Therapeutics, down from $491000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q2 2025 to a low of -$392000.0 in Q3 2025.
- The 3-year median for Amortizatization of Intangibles is $697000.0 (2025), against an average of $573666.7.
- Peak annual rise in Amortizatization of Intangibles reached 61.5% in 2025, while the deepest fall reached 139.32% in 2025.
- Sionna Therapeutics' Amortizatization of Intangibles stood at $790000.0 in 2024, then sank by 37.85% to $491000.0 in 2025, then tumbled by 59.27% to $200000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $200000.0 (Q1 2026), $491000.0 (Q4 2025), and -$392000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Sep 30, 2025 | -392,000.00 |
| Sep 30, 2025 | -392,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 697,000.00 |
| Mar 31, 2025 | 697,000.00 |
| Dec 31, 2024 | 790,000.00 |
| Dec 31, 2024 | 790,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Jun 30, 2024 | 722,000.00 |
| Jun 30, 2024 | 722,000.00 |
| Mar 31, 2024 | 492,000.00 |
| Mar 31, 2024 | 492,000.00 |